The vote happened Thursday as part of a weeklong meeting where the FDA's advisory committee reviewed seven experimental, injectable peptides to decide whether compounding pharmacies should be able to dispense them
Tirzepatide is a dual GLP-1RA and glucose-dependent insulinotropic polypeptide receptor agonist, exerting synergistic effects on insulin secretion and weight reduction [4], and offering enhanced efficacy compared to semaglutide
Excessive appetite suppression poses nutritional risks
6 week Semaglutide weight loss program mitchellshealthcli Sep 14, 2023 2 min read Updated: Sep 16, 2023 Semaglutide suppresses your appetite, stop late night craving, makes you feel fuller longer, regulates your pancreas to secrete the proper amount of insulin
Mechanism of Action Semaglutide helps with weight loss through several mechanisms